4 years of revenue, earnings, cash-flow and balance-sheet history from public filings.
Aurinia Pharmaceuticals Inc. (AUPH) operates in the Biotechnology industry and is headquartered in Edmonton, Canada with about 128 employees. Its market capitalization is roughly $2 billion. In the fiscal year ended 2025-12-31, AUPH reported $283M in revenue and $287M in net income.
Aurinia Pharmaceuticals Inc., a biopharmaceutical company, engages in delivering therapies to people living with autoimmune diseases with high unmet medical needs in the United States and Japan. The company offers LUPKYNIS (voclosporin), an oral therapy for the treatment of adult patients with active lupus nephritis.
Interactive charts & full statements → Open the AUPH valuation workbench →
| Income statement | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Total Revenue | $283M | $235M | $176M | $134M | — |
| Gross Profit | $250M | $207M | $161M | $128M | — |
| Operating Income (EBIT) | $107M | $18M | ($92M) | ($112M) | — |
| Net Income | $287M | $6M | ($78M) | ($108M) | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Quarterly income statement | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|---|---|
| Total Revenue | $78M | $77M | $74M | $70M | $62M | — |
| Gross Profit | $71M | $68M | $65M | $63M | $54M | — |
| Operating Income (EBIT) | $41M | $33M | $30M | $20M | $23M | — |
| Net Income | $34M | $211M | $32M | $22M | $23M | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Balance sheet | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Total Assets | $752M | $551M | $548M | $471M | — |
| Total Liabilities | $170M | $173M | $170M | $65M | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive AUPH viewer.
About TickerBase · Data methodology & sources